4.5 Article

Somatic Sequencing and Microsatellite Instability Results From Mismatch Repair-deficient Endometrial Carcinoma Patients Without Lynch Syndrome (Lynch-like tumors) Implications for Heritable Cancer Screening, Molecular Prognostication, and Immunotherapeutic Vulnerability

Related references

Note: Only part of the references are listed.
Article Oncology

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline

Praveen Vikas et al.

Summary: The College of American Pathologists (CAP) has developed a guideline on testing for mismatch repair (MMR) and microsatellite instability (MSI) for patients considered for immune checkpoint inhibitor therapy. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. ASCO endorses the recommendations from the CAP guideline.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medical Laboratory Technology

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer

Angela N. Bartley et al.

Summary: This study aims to develop an evidence-based guideline to identify the optimal clinical laboratory test for identifying defects in DNA mismatch repair in patients with solid tumor malignancies who are being considered for immune checkpoint inhibitor therapy.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)

Editorial Material Gastroenterology & Hepatology

Somatic Nonepigenetic Mismatch Repair Gene Aberrations Underly Most Mismatch Repair-Deficient Lynch-Like Tumors

Lisa Elze et al.

GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer

Franceska Dedeurwaerdere et al.

Summary: The study compared the diagnostic performance of three molecular MSI assays in colorectal and endometrial cancers, showing similar results and 100% sensitivity and specificity in colorectal cancer. Despite lower sensitivity in endometrial cancer, it is recommended to use a combination of IHC and molecular methods for dMMR detection.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le et al.

SCIENCE (2017)

Article Pathology

Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors

Rashmi S. Goswami et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)

Article Pathology

Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma

Jaclyn C. Watkins et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Article Pathology

Lynch Syndrome Screening in the Gynecologic Tract Current State of the Art

Anne M. Mills et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Article Oncology

A clinically applicable molecular-based classification for endometrial cancers

A. Talhouk et al.

BRITISH JOURNAL OF CANCER (2015)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Pathology

Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer

Anne M. Mills et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)

Article Gastroenterology & Hepatology

Colon and Endometrial Cancers With Mismatch Repair Deficiency Can Arise From Somatic, Rather Than Germline, Mutations

Sigurdis Haraldsdottir et al.

GASTROENTEROLOGY (2014)

Editorial Material Gastroenterology & Hepatology

Differentiating Lynch-Like From Lynch Syndrome

John M. Carethers

GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors

Arjen R. Mensenkamp et al.

GASTROENTEROLOGY (2014)

Review Oncology

EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients

Marjolijn J. L. Ligtenberg et al.

FAMILIAL CANCER (2013)

Article Oncology

Cancer risk in Lynch Syndrome

Emma Barrow et al.

FAMILIAL CANCER (2013)

Article Gastroenterology & Hepatology

Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation

Maria Rodriguez-Soler et al.

GASTROENTEROLOGY (2013)

Article Multidisciplinary Sciences

Integrated genomic characterization of endometrial carcinoma

Gad Getz et al.

NATURE (2013)